KEY FINDINGS
The Asia-Pacific cell therapy market is predicted to record a CAGR of 15.16% during the forecast period, 2022-2030. Asia-Pacific offers cost-effective manufacturing & operating units for conducting research. Also, several international corporations are increasing their investments in cell therapy in the region. In addition, many companies are collaborating to develop cell therapy products.
MARKET INSIGHTS
Singapore, Thailand, Singapore, Japan, China, India, Australia & New Zealand, and Rest of Asia-Pacific are analyzed for the Asia-Pacific cell therapy market growth assessment. Japan places a strategic emphasis on regenerative medicine due to its geriatric population and its healthcare solutions. Accordingly, the nation has spent millions of dollars on induced pluripotent stem cell research for treating sick organs. Additionally, the country has established itself as a center for induced pluripotent stem cell ((iPS cell) technology. Besides, funding agencies are offering grants to research communities to accelerate stem cell-based scientific research.
Further, companies are submitting applications to the regulatory authorities for approval to commercialize cell therapy products. For instance, Takeda Pharmaceutical Company Limited applied to the Japanese Ministry of Health, Labour, and Welfare in February 2021 to market and manufacture darvadstrocel (development code: Cx601) for treating complex perianal fistulas in Crohn's disease (CD) patients.
In India, as per the Ministry of Health and Family Welfare, around 800,000 new cancer cases are diagnosed annually. For cancers like leukemia, CAR T-cell therapy has the potential to minimize the three-year conventional treatment using bone marrow transplant, chemotherapy, oral drugs, etc., in just three weeks. As a result, the increasing need for cell therapies is projected to influence market growth.
COMPETITIVE INSIGHTS
Some of the prominent market players are JCR Pharmaceuticals Co Ltd, Vericel Corporation, Stemedica Cell Technologies Inc, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Asia-Pacific Cell Therapy Market Forecast 2022-2030
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Cellular Therapy Clinical Trials
3.1.2. Growth Of Regenerative Medicine
3.1.3. High Prevalence Of Chronic Diseases
3.2. Key Restraints
3.2.1. Increasing Skills Gap
3.2.2. High Costs
4. Key Analytics
4.1. Impact Of Covid-19 On Cell Therapy Market
4.2. Key Market Trends
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Regulatory Framework
4.5. Opportunity Matrix
4.6. Vendor Landscape
5. Market By Cell Type
5.1. Stem Cell
5.1.1. Bone Marrow
5.1.2. Blood
5.1.3. Umbilical Cord-Derived Stem Cell
5.1.4. Adipose-Derived Stem Cell
5.1.5. Others
5.2. Non-Stem Cell
6. Market By Therapy Type
6.1. Autologous
6.2. Allogeneic
7. Market By Therapeutic Application
7.1. Malignancies
7.2. Musculoskeletal Disorders
7.3. Autoimmune Disorders
7.4. Dermatology
7.5. Other Applications
8. Market By End-User
8.1. Hospitals & Clinics
8.2. Academic & Research Institutes
9. Geographical Analysis
9.1. Asia-Pacific
9.1.1. Market Size & Estimates
9.1.2. Key Drivers
9.1.3. Key Challenges
9.1.4. Key Players
9.1.5. Country Analysis
9.1.5.1. China
9.1.5.2. Japan
9.1.5.3. India
9.1.5.4. South Korea
9.1.5.5. Thailand
9.1.5.6. Singapore
9.1.5.7. Australia & New Zealand
9.1.5.8. Rest Of Asia-Pacific
10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions
10.2. Company Profiles
10.2.1. Anterogen Co Ltd
10.2.2. Bristol Myers Squibb Company
10.2.3. Cells For Cells Sa
10.2.4. Gilead Sciences Inc
10.2.5. Jcr Pharmaceuticals Co Ltd
10.2.6. Kolon Tissuegene Inc
10.2.7. Medipost Co Ltd
10.2.8. Mesoblast Limited
10.2.9. Nuvasive Inc
10.2.10. Smith & Nephew Plc
10.2.11. Stemedica Cell Technologies Inc
10.2.12. Vericel Corporation
List Of Tables
Table 1: Market Snapshot - Cell Therapy
Table 2: Regulatory Framework
Table 3: Asia-Pacific Cell Therapy Market, By Cell Type, Historical Years, 2018-2021 (In $ Million)
Table 4: Asia-Pacific Cell Therapy Market, By Cell Type, Forecast Years, 2022-2030 (In $ Million)
Table 5: Asia-Pacific Cell Therapy Market, By Stem Cell, Historical Years, 2018-2021 (In $ Million)
Table 6: Asia-Pacific Cell Therapy Market, By Stem Cell, Forecast Years, 2022-2030 (In $ Million)
Table 7: Asia-Pacific Cell Therapy Market, By Therapy Type, Historical Years, 2018-2021 (In $ Million)
Table 8: Asia-Pacific Cell Therapy Market, By Therapy Type, Forecast Years, 2022-2030 (In $ Million)
Table 9: Asia-Pacific Cell Therapy Market, By Therapeutic Application, Historical Years, 2018-2021 (In $ Million)
Table 10: Asia-Pacific Cell Therapy Market, By Therapeutic Application, Forecast Years, 2022-2030 (In $ Million)
Table 11: Asia-Pacific Cell Therapy Market, By End-User, Historical Years, 2018-2021 (In $ Million)
Table 12: Asia-Pacific Cell Therapy Market, By End-User, Forecast Years, 2022-2030 (In $ Million)
Table 13: Asia-Pacific Cell Therapy Market, By Country, Historical Years, 2018-2021 (In $ Million)
Table 14: Asia-Pacific Cell Therapy Market, By Country, Forecast Years, 2022-2030 (In $ Million)
Table 15: Key Players In Asia-Pacific Cell Therapy Market
Table 16: List Of Mergers & Acquisitions
Table 17: List Of Product Launches & Developments
Table 18: List Of Partnerships & Agreements
Table 19: List Of Business Expansions
List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter's Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Asia-Pacific Cell Therapy Market, Growth Potential, By Cell Type, In 2021
Figure 6: Asia-Pacific Cell Therapy Market, By Stem Cell, 2022-2030 (In $ Million)
Figure 7: Asia-Pacific Cell Therapy Market, Growth Potential, By Stem Cell, In 2021
Figure 8: Asia-Pacific Cell Therapy Market, By Bone Marrow, 2022-2030 (In $ Million)
Figure 9: Asia-Pacific Cell Therapy Market, By Blood, 2022-2030 (In $ Million)
Figure 10: Asia-Pacific Cell Therapy Market, By Umbilical Cord-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 11: Asia-Pacific Cell Therapy Market, By Adipose-Derived Stem Cell, 2022-2030 (In $ Million)
Figure 12: Asia-Pacific Cell Therapy Market, By Others, 2022-2030 (In $ Million)
Figure 13: Asia-Pacific Cell Therapy Market, By Non-Stem Cell, 2022-2030 (In $ Million)
Figure 14: Asia-Pacific Cell Therapy Market, Growth Potential, By Therapy Type, In 2021
Figure 15: Asia-Pacific Cell Therapy Market, By Autologous, 2022-2030 (In $ Million)
Figure 16: Asia-Pacific Cell Therapy Market, By Allogeneic, 2022-2030 (In $ Million)
Figure 17: Asia-Pacific Cell Therapy Market, Growth Potential, By Therapeutic Application, In 2021
Figure 18: Asia-Pacific Cell Therapy Market, By Malignancies, 2022-2030 (In $ Million)
Figure 19: Asia-Pacific Cell Therapy Market, By Musculoskeletal Disorders, 2022-2030 (In $ Million)
Figure 20: Asia-Pacific Cell Therapy Market, By Autoimmune Disorders, 2022-2030 (In $ Million)
Figure 21: Asia-Pacific Cell Therapy Market, By Dermatology, 2022-2030 (In $ Million)
Figure 22: Asia-Pacific Cell Therapy Market, By Other Applications, 2022-2030 (In $ Million)
Figure 23: Asia-Pacific Cell Therapy Market, Growth Potential, By End-User, In 2021
Figure 24: Asia-Pacific Cell Therapy Market, By Hospitals & Clinics, 2022-2030 (In $ Million)
Figure 25: Asia-Pacific Cell Therapy Market, By Academic & Research Institutes, 2022-2030 (In $ Million)
Figure 26: Asia-Pacific Cell Therapy Market, Country Outlook, 2021 & 2030 (In %)
Figure 27: China Cell Therapy Market, 2022-2030 (In $ Million)
Figure 28: Japan Cell Therapy Market, 2022-2030 (In $ Million)
Figure 29: India Cell Therapy Market, 2022-2030 (In $ Million)
Figure 30: South Korea Cell Therapy Market, 2022-2030 (In $ Million)
Figure 31: Thailand Cell Therapy Market, 2022-2030 (In $ Million)
Figure 32: Singapore Cell Therapy Market, 2022-2030 (In $ Million)
Figure 33: Australia & New Zealand Cell Therapy Market, 2022-2030 (In $ Million)
Figure 34: Rest Of Asia-Pacific Cell Therapy Market, 2022-2030 (In $ Million)
Global Animal Stem Cell Therapy Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 89
Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing The sample to concentrate The stem cells. Finally, The therapy includes transferring The stem cells into The injured site ......
Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 104
According to our LPI (LP Information) latest study, the global Mesenchymal Stem Cells market size was valued at US$ 202.6 million in 2023. With growing demand in downstream market, the Mesenchymal Stem Cells is forecast to a readjusted size of US$ 278.8 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Mesenchymal Stem Cells market. Mesenchymal Stem Cells are expected to show stable growth in the future market. How......
Global Stem Cells Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Stem Cells market size was valued at US$ 2693.1 million in 2023. With growing demand in downstream market, the Stem Cells is forecast to a readjusted size of US$ 5700.6 million by 2030 with a CAGR of 11.3% during review period.
The research report highlights the growth potential of the global Stem Cells market. Stem Cells are expected to show stable growth in the future market. However, product differentiation, reducing costs......
Global Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 88
According to our LPI (LP Information) latest study, the global Stem Cell Therapy market size was valued at US$ 469.1 million in 2023. With growing demand in downstream market, the Stem Cell Therapy is forecast to a readjusted size of US$ 1724 million by 2030 with a CAGR of 20.4% during review period.
The research report highlights the growth potential of the global Stem Cell Therapy market. Stem Cell Therapy are expected to show stable growth in the future market. However, product differ......
Global Animal Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Animal Stem Cell Therapy market size was valued at US$ 199.3 million in 2023. With growing demand in downstream market, the Animal Stem Cell Therapy is forecast to a readjusted size of US$ 476.2 million by 2030 with a CAGR of 13.2% during review period.
The research report highlights the growth potential of the global Animal Stem Cell Therapy market. Animal Stem Cell Therapy are expected to show stable growth in the future ma......
Global Stem Cell Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Stem Cell market:
According to our latest research, the global Stem Cell market looks promising in the next 5 years. As of 2022, the global Stem Cell market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells.
......
Global Animal Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 112
According to our (Global Info Research) latest study, the global Animal Stem Cell Therapy market size was valued at USD 209.7 million in 2023 and is forecast to a readjusted size of USD 469.9 million by 2030 with a CAGR of 12.2% during review period.
Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or di......
Global Hematopoietic Stem Cells Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 114
Market Overview of Global Hematopoietic Stem Cells market:
According to our latest research, the global Hematopoietic Stem Cells market looks promising in the next 5 years. As of 2022, the global Hematopoietic Stem Cells market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
Global Adipose Stem Cells (ASCS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 122
Market Overview of Global Adipose Stem Cells (ASCS) market:
According to our latest research, the global Adipose Stem Cells (ASCS) market looks promising in the next 5 years. As of 2022, the global Adipose Stem Cells (ASCS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
